Overview of the risk factors, prevention and management of SARS-COV-2
This thesis report is submitted in partial fulfillment of the requirement for the degree of Master of Science in Biotechnology, 2020.
Auteur principal: | Mustafa, Nashrah |
---|---|
Autres auteurs: | Hossain, Mahboob |
Format: | Thèse |
Langue: | en_US |
Publié: |
Brac University
2021
|
Sujets: | |
Accès en ligne: | http://hdl.handle.net/10361/14501 |
Documents similaires
-
In-silico based vaccine development: targeting nucleocapsid protein of SARS-CoV-2.
par: Iva, Yesmine Akter
Publié: (2022) -
Detection of genetic diversity of SARS-CoV-2 in wastewater to monitor COVID-19 transmission
par: Sarwar, Subyeta Binte
Publié: (2024) -
An in silico Method to developing an epitope-based peptide vaccination against SARS-CoV-2's Envelope Protein (E)
par: Intesar, Mohammad Nafees
Publié: (2023) -
Omicron, delta, and beta, deadliest among SARS-CoV-2 variants: an in silico analysis
par: Bosu, Sagar
Publié: (2023) -
Wave-wise comparison of COVID 19 based on SARS-CoV-2 Variants of Concern (VOCs) in Bangladesh, India, Sri Lanka, Pakistan, Nepal and the probable reasons behind the less devastating effects of Delta variant in Bangladesh: a review
par: Hasan, Mahfuzul, et autres
Publié: (2022)